SciSparc Ltd. Announces $2.2 Million Securities Offering
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
SciSparc Ltd. ( (SPRC) ) has provided an announcement.
On November 27, 2025, SciSparc Ltd. announced a securities purchase agreement with institutional and accredited investors to issue 1,292,557 ordinary shares at $1.75 each, aiming to raise approximately $2.2 million. The proceeds will be used for working capital and general corporate purposes. This strategic financial move is expected to bolster SciSparc’s operational capabilities and enhance its market position in the biotechnology sector.
More about SciSparc Ltd.
SciSparc Ltd. is a company based in Tel Aviv, Israel, operating in the biotechnology industry. It focuses on developing therapies for the treatment of disorders related to the central nervous system.
Average Trading Volume: 5,321,859
Technical Sentiment Signal: Sell
Current Market Cap: $3.6M
See more data about SPRC stock on TipRanks’ Stock Analysis page.
